Home > Insider Trading > Filing (0001209191-19-013268)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876378	Transenterix Inc.	TRXC	Surgical & Medical Instruments & Apparatus (3841)	112962080

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246530	P Joseph Slattery	C/O Transenterix, Inc. 635 Davis Drive, Suite 300 Morrisville NC 27560	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-02-21	17,650	$3.25	44,929	No	4	S	Direct
Common Stock	Acquisiton	2019-02-22	26,292	$1.39	71,221	No	4	M	Direct
Common Stock	Disposition	2019-02-22	71,221	$3.25	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2019-02-22	26,292	$0.00	26,292	$1.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
774,708		2028-02-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,000	Indirect	By IRA

Footnotes

The transactions occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c) with these sales hitting an established sales price trigger of $3.25 per share.
Following the sales on February 21, 2019 and February 22, 2019, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 2,448,178 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 931,999 shares of common stock subject to forfeiture restrictions.
Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the reporting person's Employment Agreement with the Company.